CORRECTED-Valeant cuts revenue, profit forecasts
(Corrects paragraph 1 to remove reference to 2016)
Dec 16 (Reuters) - Canadian drugmaker Valeant Pharmaceuticals International Inc cut its revenue and profit forecasts for 2015.
The company, which is holding its investor day on Wednesday, said it still expected double-digit sales growth through higher volumes. (Reporting by Vidya L Nathan in Bengaluru; Editing by Sriraj Kalluvila)
© Thomson Reuters 2017 All rights reserved.